Jennifer Kern Sliwa
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 26, 2024
Correction: Pharmacokinetic Characteristics of Long‑Acting Injectable Antipsychotics for Schizophrenia: An Overview.Christoph U Correll, Edward Kim, Jennifer Kern Sliwa
|Apr 01, 2024
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.Jennifer Kern Sliwa, Ronaldo R Naranjo, Ibrahim Turkoz
|Jan 28, 2021
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.Christoph U Correll, Edward Kim, Jennifer Kern Sliwa
|Dec 28, 2018
Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics.Christoph U Correll, Jennifer Kern Sliwa, Dean M Najarian
|Feb 16, 2018
An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate.Jennifer Kern Sliwa, Adam Savitz, Isaac Nuamah
Pageof 1
Frequent Collaborators
3 joint publications
Christoph U Correll
2 joint publications
Edward Kim
2 joint publications
Wayne Hamm
2 joint publications
Srihari Gopal
2 joint publications
Maju Mathews
2 joint publications
Raja Venkatasubramanian
2 joint publications
Stephen R Saklad
1 joint publications
Dean M Najarian
1 joint publications
Madhukar Trivedi
